Drug Guide

Generic Name

Nicardipine Hydrochloride

Brand Names Cardene, Cardene In 4.8% Dextrose In Plastic Container, Cardene In 0.86% Sodium Chloride In Plastic Container, Cardene In 0.83% Sodium Chloride In Plastic Container, Cardene In 5.0% Dextrose In Plastic Container, Cardene SR

Classification

Therapeutic: Antihypertensive, Vasodilator

Pharmacological: Calcium Channel Blocker (Dihydropyridine)

FDA Approved Indications

Mechanism of Action

Nicardipine selectively inhibits the influx of calcium ions into vascular smooth muscle and cardiac muscle, leading to vasodilation and decreased blood pressure.

Dosage and Administration

Adult: Typically starts at 5 mg/hr, titrate up every 5-15 min to a maximum of 15 mg/hr based on response and tolerability.

Pediatric: Use not well established; consulting specific pediatric guidelines is recommended.

Geriatric: Start at lower doses due to increased sensitivity; monitor closely.

Renal Impairment: Use with caution; dose adjustments may be necessary.

Hepatic Impairment: Use with caution; adjust dosing as needed.

Pharmacokinetics

Absorption: Rapid after IV administration.

Distribution: Widely distributed; crosses the placenta.

Metabolism: Primarily hepatic via CYP3A4.

Excretion: Metabolites excreted in urine and feces.

Half Life: Approx 2.5 to 4 hours.

Contraindications

Precautions

Adverse Reactions - Common

Adverse Reactions - Serious

Drug-Drug Interactions

Drug-Food Interactions

Drug-Herb Interactions

N/A

Nursing Implications

Assessment: Monitor blood pressure, heart rate, and rhythm regularly during therapy. Watch for signs of hypersensitivity.

Diagnoses:

  • Impaired tissue perfusion related to vasodilation
  • Risk for hypotension

Implementation: Administer IV infusion as prescribed, monitor vitals closely, titrate dose based on response.

Evaluation: Assess reduction in blood pressure and symptom relief, monitor for adverse effects.

Patient/Family Teaching

Special Considerations

Black Box Warnings:

Genetic Factors: None established.

Lab Test Interference: None known.

Overdose Management

Signs/Symptoms: Severe hypotension, reflex tachycardia, dizziness, possibly collapse.

Treatment: Discontinue drug, provide supportive care, consider vasopressors if hypotension persists, and administer activated charcoal if ingestion was recent.

Storage and Handling

Storage: Store at room temperature, away from light and moisture.

Stability: Stable under recommended storage conditions.

This guide is for educational purposes only and is not intended for clinical use.